| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |